Vivinex Impress XY1-EM vs RayOne EMV

Sponsor
Medical University of Bialystok
Study ID
NCT06891092
Status
Recruiting
Apply to this trial

Conditions

  • Cataract

Eligibility Criteria

Sex
ALL
Age
21 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • RayOne EMV — DEVICE
    non-diffractive monofocal IOL
  • Vivinex Impress — DEVICE
    non-diffractive monofocal IOL

Study Details

Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract

Key Dates

First listed
Mar 24, 2025
Start date
Jan 1, 2026
Status verified
Jan 2026
Primary completion
Jun 1, 2027
Completion
Jun 1, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Rayone EMV
    Patient will receive the non-diffractive monofocal IOL during cataract surgery
  • Experimental: Vivinex Impress XY1-EM
    Patient will receive the non-diffractive monofocal IOL during cataract surgery

Primary Outcome Measure

Visual acuity at intermediate distance [ Time Frame: 3 months ]

Central Contacts

Related Studies